Clinical course and prognostic factors following bone recurrence from breast cancer
1998

Prognostic Factors in Bone Recurrence from Breast Cancer

Sample size: 367 publication Evidence: moderate

Author Information

Author(s): RE Coleman, P Smith, RD Rubens

Primary Institution: Guy's Hospital

Hypothesis

What are the clinical and pathological factors that influence survival after the development of bone metastases in breast cancer patients?

Conclusion

Patients with bone-only disease have a better prognosis than those who develop metastases at other sites.

Supporting Evidence

  • Patients with lobular carcinoma and little axillary lymph node involvement were more likely to have bone-only disease.
  • Histological grade and oestrogen receptor status were significant prognostic factors for survival.
  • Patients with a disease-free interval of more than 3 years had better survival rates.

Takeaway

This study looked at women with breast cancer that spread to their bones and found that some factors can help predict how long they might live after that happens.

Methodology

The study reviewed clinical and tumor characteristics of 367 women with first distant metastasis in the skeleton, assessing various prognostic factors.

Potential Biases

Potential biases in patient selection and treatment protocols over the study period.

Limitations

The study is retrospective and may not account for all variables influencing outcomes.

Participant Demographics

All participants were women with a mean age of 56 years, presenting to the Breast Unit at Guy's Hospital between 1975 and 1990.

Statistical Information

P-Value

< 0.0001

Confidence Interval

1.2-2.4

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication